Search Results - "Taimela, E"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Economic burden and quality of life impairment increase with severity of PD by Keränen, T, Kaakkola, S, Sotaniemi, K, Laulumaa, V, Haapaniemi, T, Jolma, T, Kola, H, Ylikoski, A, Satomaa, O, Kovanen, J, Taimela, E, Haapaniemi, H, Turunen, H, Takala, A

    Published in Parkinsonism & related disorders (2003)
    “…Purpose. To define the interrelationship between cost-of-illness, quality of life (QoL) and Parkinson's disease (PD) severity in a common patient management…”
    Get full text
    Journal Article
  2. 2

    The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson’s disease by Haapaniemi, T H, Sotaniemi, K A, Sintonen, H, Taimela, E

    “…Objectives: To test the validity and feasibility of the generic 15D health related quality of life (HRQoL) instrument in Parkinson’s disease (PD) and compare…”
    Get full text
    Journal Article
  3. 3

    Third generation time-resolved immunofluorometric TSH assay for automatic immunoassay system evaluated by Taimela, E, Aalto, M, Viikari, J, Nuutila, P, Irjala, K

    “…We evaluated a new, third generation assay for serum thyrotropin (TSH) based on time-resolved fluorescence (AutoDelfia hTSH Ultra) for the 1235 AutoDelfia…”
    Get more information
    Journal Article
  4. 4

    Time-resolved immunofluorometric assay for thyrotropin improved for enhanced functional sensitivity and clinical discrimination by Taimela, E, Koskinen, P, Irjala, K

    “…Modification of a new commercial time-resolved immunofluorometric assay for thyrotropin (DelfiaR hTSH Ultra) by prediluting samples, reducing tracer…”
    Get more information
    Journal Article
  5. 5

    Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients by Taimela, E, Koskinen, P, Nuutila, P, Nikkanen, V, Saraste, M, Taimela, S, Irjala, K

    “…We evaluated the value of serum-free thyroid hormone and thyrotropin (TSH) concentrations in the detection of peripheral hyperthyroidism during thyroxine…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Clinical and laboratory studies of time-resolved fluorescence immunoassays of thyrotropin and free triiodothyronine by Taimela, E, Aalto, M, Koskinen, P, Irjala, K

    Published in Clinical chemistry (Baltimore, Md.) (01-04-1993)
    “…We evaluated a new time-resolved immunofluorometric assay (TR-IFMA) for thyrotropin (TSH) and a time-resolved fluoroimmunoassay (TR-FIA) for free…”
    Get more information
    Journal Article
  8. 8

    Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH by Taimela, E, Tähtelä, R, Koskinen, P, Nuutila, P, Forsström, J, Taimela, S, Karonen, S L, Välimäki, M, Irjala, K

    Published in Clinical chemistry (Baltimore, Md.) (01-01-1994)
    “…We evaluated the ability of new thyrotropin (TSH) assays to separate hyperthyroid (n = 50) patients from clinically euthyroid subjects with low TSH values…”
    Get more information
    Journal Article
  9. 9

    Accelerated bone degradation in thyroid carcinoma patients during thyroxine treatment, measured by determination of the carboxyterminal telopeptide region of type I collagen in serum by Taimela, E, Taimela, S, Nikkanen, V, Irjala, K

    “…We studied the effects of long-term suppressive thyroxine treatment on serum markers of bone collagen synthesis and degradation in thyroid carcinoma patients,…”
    Get more information
    Journal Article
  10. 10